References
Key articles
Felty AR. Chronic arthritis in the adult associated with splenomegaly and leucopenia. Bull Johns Hopkins Hosp. 1924;35:16-20.
Campion G, Maddison PJ, Goulding N, et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore). 1990;69:69-80. Abstract
Balint GP, Balint PV. Felty's syndrome. Best Pract Res Clin Rheumatol. 2004 Oct;18(5):631-45. Abstract
Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia of Felty syndrome. Blood Rev. 1996 Sep;10(3):177-84.Full text Abstract
Reference articles
1. Felty AR. Chronic arthritis in the adult associated with splenomegaly and leucopenia. Bull Johns Hopkins Hosp. 1924;35:16-20.
2. Campion G, Maddison PJ, Goulding N, et al. The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations. Medicine (Baltimore). 1990;69:69-80. Abstract
3. Balint GP, Balint PV. Felty's syndrome. Best Pract Res Clin Rheumatol. 2004 Oct;18(5):631-45. Abstract
4. Hellmich B, Pinals RS, Loughran TP Jr, et al. New clues to accrue on neutropenia in rheumatoid arthritis. Clin Immunol. 2005;117:1-5. Abstract
5. Sibley JT, Haga M, Visram DA, et al. The clinical course of Felty's syndrome compared to matched controls. J Rheumatol. 1991;18:1163-1167. Abstract
6. Almoallim H, Klinkhoff A. Longterm outcome of treatment of Felty's syndrome with intramuscular gold: case reports and recommendations for management. J Rheumatol. 2005;32:20-26. Abstract
7. Rosenstein ED, Kramer N. Felty's and pseudo-Felty's syndromes. Semin Arthritis Rheum. 1991;21:129-142. Abstract
8. Wordsworth P, Pile KD, Buckley JD, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet. 1992;51:585-591.Full text Abstract
9. Coakley G, Brooks D, Iqbal M, et al. Major histocompatibility complex haplotypic associations in Felty's syndrome and large granular lymphocyte syndrome are secondary to allelic association with HLA-DRB1 *0401. Rheumatology (Oxford). 2000;39:393-398.Full text Abstract
10. Coakley G, Iqbal M, Brooks D, et al. CD8+, CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: implications for the neutropenia of Felty's and large granular lymphocyte syndromes. Arthritis Rheum. 2000;43:834-843.Full text Abstract
11. Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukaemia and Felty syndrome. Blood Rev. 2006;20:245-266. Abstract
12. Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheumatology (Oxford). 2009;48:716-720. Abstract
13. Breedveld FC, Fibbe WE, Cats A. Neutropenia and infections in Felty's syndrome. Br J Rheumatol. 1988;27:191-197. Abstract
14. Bowman SJ, Sivakumaran M, Snowden N, et al. The large granular lymphocyte syndrome with rheumatoid arthritis: immunogenetic evidence for a broader definition of Felty's syndrome. Arthritis Rheum. 1994;37:1326-1330. Abstract
15. Turesson C, Jacobsson LTH, Sturfelt G, et al. Rheumatoid factor and antibodies to cyclic citrullinated peptides are associated with severe extra-articular manifestations in rheumatoid arthritis. Ann Rheum Dis. 2007;66:59-64. Abstract
16. Wassenberg S, Herborn G, Rau R. Methotrexate treatment in Felty's syndrome. Br J Rheumatol. 1998;37:908-911.Full text Abstract
17. Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia of Felty syndrome. Blood Rev. 1996 Sep;10(3):177-84.Full text Abstract
18. Lekharaju V, Chattopadhyay C. Efficacy of rituximab in Felty's syndrome. Ann Rheum Dis. 2008;67:1352. Abstract
19. Chandra PA, Margulis Y, Schiff C. Rituximab is useful in the treatment of Felty's syndrome. Am J Ther. 2008;15:321-322. Abstract
20. Weinreb N, Rabinowitz A, Dellaripa PF. Beneficial response to rituximab in refractory Felty syndrome. J Clin Rheumatol. 2006;12:48. Abstract
21. Narváez J, Domingo-Domenech E, Gómez-Vaquero C, et al. Biological agents in the management of Felty's syndrome: a systematic review. Semin Arthritis Rheum. 2012 Apr;41(5):658-68. Abstract
22. Talip F, Walker N, Khan W, et al. Treatment of Felty's syndrome with leflunomide. J Rheumatol. 2001;28:868-870. Abstract
23. Ishikawa K, Tsukada Y, Tamura S, et al. Salazosulfapyridine-induced remission of Felty's syndrome along with significant reduction in neutrophil-bound immunoglobulin G. J Rheumatol. 2003;30:404-406. Abstract
24. Wu D, Luo Y, Li T, et al. Systemic complications of rheumatoid arthritis: focus on pathogenesis and treatment. Front Immunol. 2022 Dec 22:13:1051082.Full text Abstract
25. Hellmich B, Schnabel A, Gross WL. Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor. Semin Arthritis Rheum. 1999;29:82-99. Abstract
26. Laszlo J, Jones R, Silberman HR, et al. Splenectomy for Felty's syndrome: clinopathological study of 27 patients. Arch Intern Med. 1978;138:597-602. Abstract
27. Ghavami A, Genevay S, Fulpius T, et al. Etanercept in treatment of Felty's syndrome. Ann Rheum Dis. 2005;64:1090-1091.Full text Abstract
28. Hamada-Ode K, Taniguchi Y, Shimamura Y, et al. Efficacy of abatacept for Felty's syndrome. Rheumatology (Oxford). 2020 Jan 1;59(1):256-9.Full text Abstract
29. Li R, Wan Q, Chen P, et al. Tocilizumab treatment in Felty's syndrome. Rheumatol Int. 2020 Jul;40(7):1143-9.Full text Abstract
30. American College of Rheumatology. 2022 American College of Rheumatology (ACR) guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Feb 2023 [internet publication].Full text
31. Bowman SJ, Bhavnani M, Geddes GC, et al. Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol. 1995;101:18-24.Full text Abstract
32. Owlia MB, Newman K, Akhtari M. Felty's Syndrome, Insights and Updates. Open Rheumatol J. 2014;8:129-36.Full text Abstract
33. Stock H, Kadry Z, Smith JP. Surgical management of portal hypertension in Felty's syndrome: a case report and literature review. J Hepatol. 2009;50:831-835. Abstract
Use of this content is subject to our disclaimer